• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Post-partum Implanon offers long-term contraception for high risk women

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
May 18, 2014
in Obstetrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Two-thirds of women who had an implanon placed immediately post-partum used the birth control method for the entirety of its 3-year lifespan. 

2. Continuation rates were higher in women at highest risk for recurrent pregnancy, including adolescents and those with poor prenatal care. 

Evidence Rating Level: 2 (Good)           

Study Rundown: This study found that the continuation rate for women who received an implanon, a 3-year long-acting reversible contraceptive method (LARC), immediately post-partum was over 66% at 3 years. Compliance rates were even higher in women who were most at risk for recurrent pregnancy, including adolescents and those with poor prenatal care. This is the first study to include behavioral variables, such as number of prenatal care visits, in the evaluation of characteristics associated with contraceptive continuation. One strength of this study is a high follow-up rate (>70%). Limitations include a relatively small sample size and lack of a control group. Future studies might try to replicate findings with a larger, multi-centered cohort and compare continuation rates between women who received post-partum implanon with other non-LARC methods.

Click to read the study in Contraception

Relevant Reading: Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference?

RELATED REPORTS

Postpartum patients may be at an increased risk of intrauterine device-related perforation

Associations between hormonal contraception and adverse health outcomes not supported by high-quality evidence

Improved contraception use with progestogen-only pill and rapid access vs emergency contraception

In-Depth [retrospective cohort]: Researchers collected data from electronic medical records for all women at an urban, academic medical center who had an etonogestrel contraceptive implant (Implanon) placed immediately postpartum between January 2008 and March 2009. The primary outcome was continuation rates at 1, 2, and 3 years (the lifetime of the implant). Secondary outcomes included characteristics of women who had the Implanon placed and adverse effects that led to early discontinuation. Of the 262 women, 28.2% were adolescents, 71.8% were multigravid and 38.5% had poor prenatal care (<6 prenatal visits).

The overall continuation rate of implanon at 3 years was 66.3%. 94.5% of adolescents and 94.1% of women with poor prenatal care (<6 visits) retained their Implanon at 1 year, as compared with 87% overall. The most common reason for discontinuation was abnormal bleeding (41%) followed by weight gain (19%).

More from this author: In elderly, robotic surgery for endometrial cancer linked with lower morbidity, Individualized pelvic floor muscle training improves prolapse symptoms, Knowledge gaps regarding fertility prevalent in reproductive aged women, IUD contraception equally safe in teenagers as in older women 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: contraceptionimplanon
Previous Post

Decreased HIV co-receptor CCR5 expression after IUD insertion

Next Post

The VIDA trial: Vitamin D3 does not improve outcomes in asthma patients

RelatedReports

AAP policy update recommends first-line contraceptives, addresses special populations
Emergency

Postpartum patients may be at an increased risk of intrauterine device-related perforation

June 15, 2022
Parental nonmedical prescription opioid use linked to adolescent use
Obstetrics

Associations between hormonal contraception and adverse health outcomes not supported by high-quality evidence

January 21, 2022
1 in 5 US women report delayed contraceptive initiation after sexual debut
Chronic Disease

Improved contraception use with progestogen-only pill and rapid access vs emergency contraception

December 9, 2020
Government-funded initiatives provide important supports to low-income HIV patients
Chronic Disease

Quick Take: HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception

June 23, 2019
Next Post
Maternal vitamin D status does not affect offspring’s bone-mineral content

The VIDA trial: Vitamin D3 does not improve outcomes in asthma patients

High BMI linked to reduced risk of endometriosis

Decreased sleep in childhood linked to later central adiposity

Pro-vaccine messages not associated with increased vaccination intent

Robust hepatitis B seroprotection in adolescence after immunization in infancy

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
  • Cognitive behavioral therapy efficacious for treatment of comorbid posttraumatic headache and posttraumatic stress disorder symptoms among US veterans
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.